Azitra, Inc. (NYSEAMERICAN:AZTR – Free Report)’s stock is set to reverse split on the morning of Monday, October 26th. The 1-10 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the closing bell on Sunday, October 25th.
Azitra Trading Up 0.7%
Azitra stock opened at $0.07 on Friday. Azitra has a 52 week low of $0.05 and a 52 week high of $1.09. The firm’s 50-day simple moving average is $0.15 and its 200 day simple moving average is $0.18.
Azitra (NYSEAMERICAN:AZTR – Get Free Report) last issued its quarterly earnings data on Wednesday, August 12th. The company reported ($0.17) EPS for the quarter, missing analysts’ consensus estimates of ($0.12) by ($0.05). As a group, sell-side analysts predict that Azitra will post -0.20 EPS for the current fiscal year.
Azitra Company Profile
Azitra, Inc is a clinical-stage biotechnology company focused on developing live biotherapeutic products for dermatological conditions. The company uses microbiome science and genetic engineering to develop beneficial bacteria designed for topical application to the skin.
Azitra’s research programs have focused on conditions including atopic dermatitis, acne vulgaris and other skin disorders associated with impaired barrier function or microbial imbalance. Its pipeline has included engineered strains of skin-associated bacteria intended to deliver therapeutic proteins or other biological effects directly to affected areas.
The company was founded in 2014 and is based in New Haven, Connecticut.
Further Reading
- Five stocks we like better than Azitra
- Rocket Lab’s Neutron Delay Leaves Wall Street Bullish But Raises the Stakes for 2027
- ManpowerGroup Stock Sinks on Q3 Results, But Fundamentals Stay Solid
- Does the AI Selloff Put Alphabet’s Breakout in Doubt?
- Bank Earnings Are Mixed—These 2 ETFs Offer Very Different Paths to a Recovery
Receive News & Ratings for Azitra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azitra and related companies with MarketBeat.com's FREE daily email newsletter.
